Ibrahim F. Benter

5.5k total citations
89 papers, 4.7k citations indexed

About

Ibrahim F. Benter is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ibrahim F. Benter has authored 89 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 38 papers in Cardiology and Cardiovascular Medicine and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ibrahim F. Benter's work include Renin-Angiotensin System Studies (30 papers), Nitric Oxide and Endothelin Effects (18 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Ibrahim F. Benter is often cited by papers focused on Renin-Angiotensin System Studies (30 papers), Nitric Oxide and Endothelin Effects (18 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Ibrahim F. Benter collaborates with scholars based in Kuwait, United States and United Kingdom. Ibrahim F. Benter's co-authors include Saghir Akhtar, Mariam H.M. Yousif, Debra I. Diz, Carlos M. Ferrario, Mubarack M. Muthalif, Kafait U. Malik, Andrew J. Hollins, Gursev S. Dhaunsi, C. Cojocel and Mustapha Benboubetra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ibrahim F. Benter

89 papers receiving 4.6k citations

Peers

Ibrahim F. Benter
Xiao-Ping Yang United States
Anindita Das United States
Kerry S. Russell United States
J. Anthony Ware United States
Xiao-Ping Yang United States
Ibrahim F. Benter
Citations per year, relative to Ibrahim F. Benter Ibrahim F. Benter (= 1×) peers Xiao-Ping Yang

Countries citing papers authored by Ibrahim F. Benter

Since Specialization
Citations

This map shows the geographic impact of Ibrahim F. Benter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim F. Benter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim F. Benter more than expected).

Fields of papers citing papers by Ibrahim F. Benter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim F. Benter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim F. Benter. The network helps show where Ibrahim F. Benter may publish in the future.

Co-authorship network of co-authors of Ibrahim F. Benter

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim F. Benter. A scholar is included among the top collaborators of Ibrahim F. Benter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim F. Benter. Ibrahim F. Benter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rachid, Ousama, et al.. (2021). Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential. Advanced Drug Delivery Reviews. 178. 113908–113908. 105 indexed citations
2.
Benter, Ibrahim F., et al.. (2021). The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications. Frontiers in Pharmacology. 12. 701390–701390. 26 indexed citations
3.
Babiker, Fawzi, Ibrahim F. Benter, & Saghir Akhtar. (2020). <p>Nanotoxicology of Dendrimers in the Mammalian Heart: ex vivo and in vivo Administration of G6 PAMAM Nanoparticles Impairs Recovery of Cardiac Function Following Ischemia-Reperfusion Injury</p>. International Journal of Nanomedicine. Volume 15. 4393–4405. 10 indexed citations
4.
Akhtar, Saghir, Ibrahim F. Benter, Mohammed Danjuma, et al.. (2020). Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. Journal of drug targeting. 28(7-8). 683–699. 36 indexed citations
5.
Dhaunsi, Gursev S., et al.. (2017). Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum. BioMed Research International. 2017. 1–7. 7 indexed citations
8.
El‐Hashim, Ahmed Z., et al.. (2012). Angiotensin‐(1–7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2‐ and NF‐κB‐dependent pathways. British Journal of Pharmacology. 166(6). 1964–1976. 129 indexed citations
10.
Benter, Ibrahim F., Mariam H.M. Yousif, Mohd Alsaleh, et al.. (2011). Angiotensin-(1-7) Blockade Attenuates Captopril- or Hydralazine-induced Cardiovascular Protection in Spontaneously Hypertensive Rats Treated With NG-nitro-l-Arginine Methyl Ester. Journal of Cardiovascular Pharmacology. 57(5). 559–567. 50 indexed citations
11.
12.
Akhtar, Saeed, Turki Almubrad, Anthony J. Bron, et al.. (2009). Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmologica. 87(8). 881–889. 17 indexed citations
13.
Yousif, Mariam H.M., Elijah O. Kehinde, & Ibrahim F. Benter. (2007). Different responses to angiotensin-(1-7) in young, aged and diabetic rabbit corpus cavernosum. Pharmacological Research. 56(3). 209–216. 26 indexed citations
14.
Benter, Ibrahim F., Mariam H.M. Yousif, C. Cojocel, May Al‐Maghrebi, & Debra I. Diz. (2007). Angiotensin-(1–7) prevents diabetes-induced cardiovascular dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 292(1). H666–H672. 145 indexed citations
15.
Yousif, Mariam H.M., Ibrahim F. Benter, & Saghir Akhtar. (2005). The role of tyrosine kinase‐mediated pathways in diabetes‐induced alterations in responsiveness of rat carotid artery. Autonomic and Autacoid Pharmacology. 25(2). 69–78. 22 indexed citations
16.
Benter, Ibrahim F., Ijaz A. Khan, C. Cojocel, et al.. (2005). Signal transduction involving Ras-GTPase contributes to development of hypertension and end-organ damage in spontaneously hypertensive rats-treated with L-NAME. Pharmacological Research. 52(5). 401–412. 11 indexed citations
17.
Benboubetra, Mustapha, Pakeeza Sayyed, Keng Wooi Ng, et al.. (2004). Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes:In VitroandIn VivoStudies. Journal of drug targeting. 12(6). 393–404. 107 indexed citations
18.
Sohail, Muhammad, Marcus D. Hughes, Ibrahim F. Benter, et al.. (2003). Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Biochemical Pharmacology. 66(5). 819–830. 26 indexed citations
20.
Benter, Ibrahim F., et al.. (1990). N-terminal degradation of low molecular weight opioid peptides in human cerebrospinal fluid. Biochemical Pharmacology. 40(3). 465–472. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026